Am J Hypertens

1. ARSLAN A, Ilis D, Artac I, Karakayali M, et al
   R-Wave Peak Time and Subclinical Left Ventricular Dysfunction in Hypertensive Patients: Insights From Speckle-Tracking Echocardiography.
   Am J Hypertens. 2025 Sep 23:hpaf180. doi: 10.1093.
   

   >> Share

   
   
2. METLOCK FE, Ogungbe O, Stanislas KA, Liu X, et al
   Hypertension and Racial/Ethnic Disparities in Sleep Outcomes among Adults in the 2011-2023 National Health and Nutrition Examination Survey.
   Am J Hypertens. 2025 Aug 22:hpaf110. doi: 10.1093.
   

   >> Share

   
   
3. SALADINI F, Rattazzi M, Palatini P
   Orthostatic hypertension, an easy to detect cardiovascular prognostic marker that cannot be neglected.
   Am J Hypertens. 2025 Sep 16:hpaf186. doi: 10.1093.
   

   >> Share

   
   
4. SPROULE T, Sargent L, Price E, Mackiewicz M, et al
   Association Between ABPM Phenotypes and Cognitive Impairment in a Community-Dwelling, Older Adult Population Taking Antihypertensive Medication: A Pilot Study.
   Am J Hypertens. 2025 Sep 16:hpaf188. doi: 10.1093.
   

   >> Share

   
   
5. HARRISON TN, Juan RA, An J, Zhou H, et al
   Blood Pressure Outcomes Following a Home Blood Pressure Monitoring Program in a Large Integrated US Health System.
   Am J Hypertens. 2025;38:833-840.
   

   >> Share

   
   
6. STOPA M, Zieba K, Tofilska A, Betkowska-Korpala B, et al
   Association of Anxiety with Discrepancies Between Unattended and Attended Office Blood Pressure Measurement.
   Am J Hypertens. 2025;38:769-776.
   

   >> Share

   
   
7. BYFIELD RL, Choi E, Cohen JB, Kronish IM, et al
   Home Blood Pressure Monitoring Among Adolescents and Young Adults, NHANES 2009-2014.
   Am J Hypertens. 2025;38:754-758.
   

   >> Share

   
   

   
   Am J Kidney Dis

8. CHURILLA T, Baker JB, Chang A, Finer G, et al
   A 16-Year-Old With a Hypertension Emergency: A Quiz.
   Am J Kidney Dis. 2025;86:A13-A16.
   

   >> Share

   
   

   
   Clin Exp Hypertens

9. JIANG G, Li X, Fang Z, Shi G, et al
   miPEP31 inhibits the vascular smooth muscle cell proliferation via cooperation with transcription factor Trps1.
   Clin Exp Hypertens. 2025;47:2561235.
   

   >> Share

   
   

   
   Eur Heart J

10. DEWLAND TA, van Dam RM, Marcus GM
    Coffee and cardiovascular disease.
    Eur Heart J. 2025;46:3546-3554.
    

    >> Share

    
    

    
    Eur J Pharmacol

11. QIN Y, Sha Z, Qiao Y, Yan G, et al
    Phospholysine phosphohistidine inorganic pyrophosphate phosphatase Suppresses Glycolysis and Proliferation of Pulmonary Artery Smooth Muscle Cells in Hypoxic Pulmonary Hypertension via Inhibition of lactate dehydrogenase A.
    Eur J Pharmacol. 2025 Sep 20:178172. doi: 10.1016/j.ejphar.2025.178172.
    

    >> Share

    
    
12. YU X, Li Q, Zhang D, Guo K, et al
    KN060-a humanized dual-domain antibody simultaneously targeting FXI-A2/A3 epitopes: Pioneering the anti-coagulation factor XI strategy for Aterial hypertension - Evidence from preclinical models.
    Eur J Pharmacol. 2025;1006:178171.
    

    >> Share

    
    

    
    Hypertension

13. SEKITOLEKO I, Byrd JB
    Artificial Intelligence: For Now, an Artificial Ingredient in Hypertension Diagnosis and Management.
    Hypertension. 2025 Sep 24. doi: 10.1161/HYPERTENSIONAHA.125.23626.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

14. FISHER M, Smith G, Potter BK, Arbuckle TE, et al
    The Association between Pregnancy Complications and Long-Term Maternal Cardiometabolic Health in the MIREC Cohort Study.
    J Clin Endocrinol Metab. 2025 Jan 23:dgaf041. doi: 10.1210.
    

    >> Share

    
    

    
    J Hum Hypertens

15. ANGELAKI E, Marketou ME, Fragkiadakis K, Maragkoudakis S, et al
    Response to letter JHH-25-0238 in relation to our article on Journal of Human Hypertension.
    J Hum Hypertens. 2025 Sep 19. doi: 10.1038/s41371-025-01065.
    

    >> Share

    
    
16. SAARINEN TP, Suojanen LJ, Choudhary MK, Mustonen J, et al
    Hyperdynamic circulation distinguishes predominantly diastolic hypertension from predominantly systolic hypertension.
    J Hum Hypertens. 2025 Sep 19. doi: 10.1038/s41371-025-01069.
    

    >> Share

    
    

    
    J Hypertens

17. XU R, Wang H, Wei Y, Jiang T, et al
    Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of spontaneously hypertensive rats through the Yes-associated protein pathway.
    J Hypertens. 2025 Aug 12. doi: 10.1097/HJH.0000000000004120.
    

    >> Share

    
    
18. LAMTI F, Trabelsi I, Dhaoui R, Hajji E, et al
    Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial.
    J Hypertens. 2025 Sep 4. doi: 10.1097/HJH.0000000000004141.
    

    >> Share

    
    
19. PREJBISZ A, Dobrowolski P, Bozek G, Kon B, et al
    Patterns of prescription of antihypertensive medications in Poland: a one-year assessment of initiation and persistence of therapy in a nationwide population cohort.
    J Hypertens. 2025 Aug 20. doi: 10.1097/HJH.0000000000004111.
    

    >> Share

    
    

    
    JAMA

20. DESAI A, Havasi A, Saxena M
    Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension-Reply.
    JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13329.
    

    >> Share

    
    
21. CHEN T, Zhu Z
    Zilebesiran Add-On Treatment for Inadequately Controlled Hypertension.
    JAMA. 2025 Sep 24. doi: 10.1001/jama.2025.13326.
    

    >> Share

    
    

    
    Kidney Int

22. TATLIGUN M, Avsar FN, Korkmaz D, Erdogan HB, et al
    The Case | A patient with malignant hypertension, thrombotic microangiopathy, and perinephric hematoma after a biopsy.
    Kidney Int. 2025;108:719-720.
    

    >> Share

    
    

    
    PLoS Comput Biol

23. ZILVES EG, Muller LO, Talou GDM, Hachinski V, et al
    Blood flow in the human cerebral cortex: Large-scale pial vascularization and 1D simulation.
    PLoS Comput Biol. 2025;21:e1013459.
    

    >> Share

    
    

    
    PLoS One

24. ALKOURI O, Albikawi Z, Saifan AR, Khatatbeh H, et al
    Stratifying atherosclerotic cardiovascular disease by SMuRF burden in a Middle-Eastern country: A multiregistry study of demographics, comorbidities, and therapeutic trends.
    PLoS One. 2025;20:e0332302.
    

    >> Share

    
    
25. ZHANG P, Liu C, Li J, Gao H, et al
    Risk factors for abdominal aortic aneurysm in general populations: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0329500.
    

    >> Share

    
    
26. WEI XY, Jiang XY, Wang L, Yan CQ, et al
    Efficacy and neural mechanism of acupuncture for essential hypertension: Study protocol for a randomized clinical trial.
    PLoS One. 2025;20:e0332268.
    

    >> Share

    
    
27. CHEN W, Zhang L, Qi H
    CD44 as a novel therapeutic target in pulmonary arterial hypertension: Insights from multi-omics integration and molecular docking.
    PLoS One. 2025;20:e0332817.
    

    >> Share

    
    
28. DANGAURA NR, Khanal P, Kuikel BS, Marasini S, et al
    Impact of National health insurance on medication adherence among hypertensive patients: A hospital-based cross-sectional study from Kailali, Nepal.
    PLoS One. 2025;20:e0332602.
    

    >> Share

    
    

    
    Stroke

29. EGLE M, Groechel RC, Johansen MC, Kucharska-Newton AM, et al
    Role of Morbidity Clusters in Midlife on Ischemic Stroke Incidence and Severity: The ARIC Study.
    Stroke. 2025 Sep 4. doi: 10.1161/STROKEAHA.124.049496.
    

    >> Share

    
    
30. BIESBROEK JM, de Kort FAS, Anblagan D, Bastin ME, et al
    Signature White Matter Hyperintensity Locations Associated With Vascular Risk Factors Derived From 15 653 Individuals.
    Stroke. 2025 Aug 20. doi: 10.1161/STROKEAHA.125.051159.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share